LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Ruxolitinib | 10 | uM | LJP5 | 72 | hr | 765 | 2151 | 3148 | 0.6833 | 0.6594 |
Hs 578T | Momelotinib | 0.04 | uM | LJP5 | 72 | hr | 765 | 2980 | 3148 | 0.9468 | 0.9471 |
Hs 578T | Momelotinib | 0.12 | uM | LJP5 | 72 | hr | 765 | 2751 | 3148 | 0.8740 | 0.8722 |
Hs 578T | Momelotinib | 0.37 | uM | LJP5 | 72 | hr | 765 | 2507 | 3148 | 0.7965 | 0.7888 |
Hs 578T | Momelotinib | 1.11 | uM | LJP5 | 72 | hr | 765 | 2178 | 3148 | 0.6920 | 0.6695 |
Hs 578T | Momelotinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 1850 | 3148 | 0.5877 | 0.5413 |
Hs 578T | Momelotinib | 10 | uM | LJP5 | 72 | hr | 765 | 754 | 3148 | 0.2395 | -0.0071 |
Hs 578T | Fedratinib | 0.04 | uM | LJP5 | 72 | hr | 765 | 3204 | 3148 | 1.0177 | 1.0170 |
Hs 578T | Fedratinib | 0.12 | uM | LJP5 | 72 | hr | 765 | 3148 | 3148 | 1.0000 | 0.9999 |
Hs 578T | Fedratinib | 0.37 | uM | LJP5 | 72 | hr | 765 | 2853 | 3148 | 0.9063 | 0.9057 |
Hs 578T | Fedratinib | 1.11 | uM | LJP5 | 72 | hr | 765 | 2156 | 3148 | 0.6851 | 0.6616 |
Hs 578T | Fedratinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 1001 | 3148 | 0.3180 | 0.1407 |
Hs 578T | Fedratinib | 10 | uM | LJP5 | 72 | hr | 765 | 321 | 3148 | 0.1021 | -0.3478 |
Hs 578T | Trametinib | 0.04 | uM | LJP5 | 72 | hr | 765 | 1192 | 3148 | 0.3787 | 0.2428 |
Hs 578T | Trametinib | 0.12 | uM | LJP5 | 72 | hr | 765 | 1051 | 3148 | 0.3338 | 0.1682 |
Hs 578T | Trametinib | 0.37 | uM | LJP5 | 72 | hr | 765 | 1038 | 3148 | 0.3298 | 0.1613 |
Hs 578T | Trametinib | 1.11 | uM | LJP5 | 72 | hr | 765 | 975 | 3148 | 0.3097 | 0.1260 |
Hs 578T | Trametinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 1001 | 3148 | 0.3182 | 0.1410 |
Hs 578T | Trametinib | 10 | uM | LJP5 | 72 | hr | 765 | 1000 | 3148 | 0.3176 | 0.1402 |
Hs 578T | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 765 | 981 | 3101 | 0.3167 | 0.1313 |
Hs 578T | Omipalisib | 0.12 | uM | LJP6 | 72 | hr | 765 | 720 | 3101 | 0.2325 | -0.0316 |
Hs 578T | Omipalisib | 0.37 | uM | LJP6 | 72 | hr | 765 | 573 | 3101 | 0.1850 | -0.1329 |
Hs 578T | Omipalisib | 1.11 | uM | LJP6 | 72 | hr | 765 | 470 | 3101 | 0.1517 | -0.2157 |
Hs 578T | Omipalisib | 3.33 | uM | LJP6 | 72 | hr | 765 | 405 | 3101 | 0.1308 | -0.2708 |
Hs 578T | Omipalisib | 10 | uM | LJP6 | 72 | hr | 765 | 358 | 3101 | 0.1157 | -0.3151 |